Close Menu

Attending scientific meetings might be a crapshoot -- they're expensive and time consuming -- but good meetings are definitely worth the resources, says DrugMonkey. Meetings are valuable for the scientific exchange that goes on, and really good ones get you "absolutely fired up about your science," he says. "When you get back to the lab, do you tear around like a wackaloon, getting new experiments and collaborations going? Then you had a GoodMeeting."

 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.

Researchers in France are developing a new, fast test for SARS-CoV-2 that initial testing indicates may be highly accurate, the Guardian says.

In Cell this week: analysis of fitness patterns among SARS-CoV-2 isolates, single-cell transcriptome analysis of immune features in COVID-19, and more.